Disc Medicine, Inc.IRONNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+72.2%
5Y CAGR+43.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+72.2%/yr
Annual compound
5Y CAGR
+43.4%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
6.1x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$170.64M+76.5%
2024$96.67M+39.6%
2023$69.26M+107.1%
2022$33.44M+32.8%
2021$25.17M-10.6%
2020$28.17M-